CSPI targets juice capsules
This article was originally published in The Tan Sheet
Executive SummaryFDA should halt the marketing of NSA's Juice Plus+ Orchard Blend and Juice Plus+ Garden Blend capsules because the products appear to be adulterated and misbranded, the Center for Science in the Public Interest says in a letter to the agency Dec. 12. CSPI says it is concerned the products' claim, "the next best thing to fruits and vegetables," may lead consumers to believe the pills are "closer to real fruits and vegetables than is likely to be the case." The labels say the capsules contain high levels of vitamins A and C and folate naturally, and do not disclose that these vitamins and minerals are added to the capsules during processing and are nutrients only characteristic of the original fruit and vegetable sources...
You may also be interested in...
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.